Germany is pressing the European Union to approve a coronavirus vaccine before Christmas. The vaccine developed by Pfizer alongside Germany’s BioNTech has already been authorized for use in the United Kingdom, United States, Canada and a host of other countries.
Host Lisa Mullins speaks with NPR’s Rob Schmitz in Berlin.
This article was originally published on WBUR.org.
Copyright 2020 NPR. To see more, visit https://www.npr.org.